The paper discusses TRIPS and indigenous medicines. It attempts to bring out issues around these two subjects that are of serious concern between developing countries and the developed countries, while developing countries boast of plenty of biodiversity resources, the developed countries have developed technologies that exploit these and commercialise them for profit at the expense of the developing countries. They use ingredients from developing countries which they patent to prohibit their use by any other individual without paying royalties and thus no benefit sharing.